2012 Annual Report - SIR Foundation


2012 Annual Report - SIR Foundation

SIR President Marshall E. Hicks, MD, FSIR, and SIR Quality Improvement Committee Chair Joseph R. Steele, MD, FSIR, met withmembers of congress to speak on issues important to IR.United States. Most filter manufacturershave agreed to participate in the study.SIR and SVS are in the process of makinga final decision for a contract researchorganization that will complete protocoldevelopment and submit the study forinvestigational device exemption (IDE)study with HIPAA (Health InsurancePortability and Accountability Act)compliance. The contract researchorganization (CRO) will then launch andmanage the study operations. Studydirectors are Matthew S. Johnson, MD,FSIR, and David L. Gillespie MD, FACS.Other policy accomplishments:• SIR members stepped up to the platein the “Save Our Seat” campaign,1.6 MILLIONVIEWS ON SIRWEB.ORG IN 2012ensuring that interventional radiologywould continue to be a key part ofAMA decisions that affect coding andreimbursement.• SIR volunteers defended IR at theAMA CPT and RBRVS (RUC) panels,resulting in new practice expenseinputs for kyphoplasty and appropriatevaluations for new bundled codes incarotid angiography and thrombolysis.• At the SIR 2012 Annual ScientificMeeting, Agency for HealthcareResearch and Quality (AHRQ) DirectorCarolyn Clancy heard firsthand fromSIR members about the critical role IRplays in delivering quality patient care.• SIR provided a letter supporting effortsby the Brazilian Society of InterventionalRadiology (SoBRICE) and the BrazilianSociety of Gynecology to successfullyreverse a decision by the BrazilianNational Agency of Health to excludecoverage of uterine fibroid embolization(UFE) to treat fibroids.• SIR launched a grassroots effortto challenge proposed IntersocietalAccreditation Commission (IAC)vascular testing standards that ignoredIR expertise, leading to more than1,000 comments from SIR membersover a one-month span. As a result, IACrevised its standards to acknowledgeradiology board certification as beingsufficient for credentialing.• Advocacy by SIR members helpedreverse a decision by a New York statemalpractice insurance carrier, MLMIC, tovoid coverage of those who performedvertebral augmentation procedures suchas kyphoplasty. The carrier agreed tocontinue coverage as long as new interventionalradiologists can document theirfellowship training through continuingmedical education, such as IR workshops.• The House Ways and Means HealthSubcommittee requested that SIRsuggest ways to improve healthcare outcomes and efficiency in theMedicare program. This opportunityreflects the growing recognition byCongress of the vital role SIR can playin delivering safe, effective, efficientpatient care.6Society of Interventional Radiology + Society of Interventional Radiology Foundation

SCIENTIFIC EDUCATIONSIR education programs help to ensure the future of the profession and equip interventional radiologists with the knowledge,skills and abilities necessary to make a difference in the world. Consistent, high-quality training prepares both IR graduatesand advanced practitioners to provide comprehensive, integrated patient care that leverages the unique qualities of the fieldfor better outcomes. SIR Foundation grants and awards programs provide benefits to researchers at all levels of training andencourages further development of interventional radiology research.Specialized Training Through LEARNEducational interventions, formerlypart of everyday life in the clinicalsetting, have become increasinglyrare, especially for certain procedures.Other successes in education include:• SIR’s Annual Scientific MeetingWebcasts enabled interventionalradiologists in the United States andabroad to engage session moderatorsonline and to benefit from interactivedistance learning. To date, nearly 500individuals have viewed the Webcasts fora total of more than 3,000 hours.The Fall Webinar Series spotlighted IO,PAD, venous and other current diseasetopics as it gave participants at 108sites the opportunity to interact onlinewith experts.• SIR’s Learning Center became fully integratedwith the CME Gateway and, by extension,to the ABR, to provide memberswith automatic tracking of educational activitiesfor maintenance of certification. In2012, 1,449 people accessed the CMEGateway via the Learning Center and1,200 had their learning credits appliedto their ABR account for Maintenance ofCertification progress tracking, eliminatingthe need to self-report earned credits.• The Catheter Lysis of ThromboembolicStroke (CLOTS) course provided aSIR’s Lower Extremity Arterial RevascularizatioN (LEARN) course provided theright education for me at the right time. The access to thought leaders in IR and theopportunity to engage one-on-one with them—as well as the ability to see and try newdevices—was more helpful than any other skill-building offering I had tried. LEARNallowed me to focus on this one topic for three straight days. Its lasting benefit wasaccess to the expertise and support of the thought leaders, which I tapped for help with adifficult case soon after. Rather than having to refer the patient to another physician, theexperience fortified my confidence that I can—and should be—treating these patients.—Hirschel D. McGinnis, MD, Morton Hospital, a Steward Family Hospital;President, New England Society for Interventional Radiologyspecialized didactic lecture and handsonstroke training to 155 attendees.In its fourth year, CLOTS has becomea forum to highlight groundbreakingimaging techniques and up-to-the-minutetherapeutic procedures.• The second Y-90: Are YoU Ready?meeting provided requisite trainingand testing for official SIR validation of169 attendees as qualified to apply forAuthorized User (AU) status for intraarterialY-90 in the treatment of hepaticmalignancies. Y-90: Are YoU Ready?ensures interventional radiologists notonly meet—but exceed—AU qualifications.• The SIR Fellows Spring Practicum providedmore than 60 IR fellows from acrossthe United States with hands-on experienceand invaluable networking opportunitiesat a decisive time in their career.150 COMPANIESHAVE SUPPORTED SIR PROFESSIONAL AND TRAINEE PROGRAMSTHIS YEAR, INCLUDING 27 NEW EXHIBITORS FOR SIR 2012.• SIR worked to connect companies tophysicians, helping them achieve theirshared goals—research, education,patient care and better outcomes—byincluding them in hands-on workshopsat meetings, providing interactionwith trainees and including them asobservers at SIR Foundation researchconsensus panel meetings.• Hands-on designation for special learningopportunities in the SIR 2012 TechnicalExhibit Hall facilitated education andnetworking between companies andinterventional radiologists.2012 Annual Report 7

FOSTERING RESEARCHResearch is the heart and soul of interventional radiology, which attractsexperimental, entrepreneurial personalities and has achieved its most significantadvances through innovation. SIR promotes research by facilitating connectionsamong researchers with common interests, while SIR Foundation provides crucialfunding for their investigations.CCSVI: Innovations in IRtwo years ago, Gary P.Siskin, MD, FSIR, and I became“Aboutinterested in the role that chroniccerebrospinal venous insufficiency(CCSVI) might play in multiple sclerosis.SIR convened a working group onCCSVI to evaluate whether MS patientswho underwent jugular angioplastyexperienced relief from their symptomsand provided an invaluable service to thefield by issuing recommendations on howtheir colleagues should proceed. Thegroup was a wonderful forum for sharingand networking among professionals whowere already performing the procedure.Support from SIR lends legitimacy toresearchers’ efforts and helps ensurewe go about them in a way that informsand serves the greater good.” —MeridithJ. Englander, MD, Assistant Professor,Albany Medical CollegeConnecting Medical Students to IR“In the summer of 2012, I received anSIR Foundation medical student researchinternship and worked for eight weeks ata device company. As a former engineerat a large device manufacturer, I benefitedfrom the different perspective of a smallercompany with more of a think tankenvironment. I learned how involvementby doctors can be multi-faceted, but alsojust how many doctors are involved in theinventive process. I wanted to be moreinvolved, to understand the process andhow I could facilitate it. The internship fromSIR Foundation made it possible and I amgrateful for the opportunity.” —MassimoTarulli, 2012 SIR Foundation SummerMedical Student Research InternOther successes in research include:• SIR Foundation sponsored a researchconsensus panel on critical limbischemia led by Sanjay Misra, MD, FSIR,Mayo Clinic, College of Medicine, andmoderated by SIR Foundation Vice ChairStephen T. Kee, MD, FSIR.• SIR Foundation received 32 grantapplications and funded 12 grants.• SIR Foundation funded six Dr.Constantin Cope Medical Student SIRAnnual Scientific Meeting ResearchAwards and three Resident/FellowSIR Annual Scientific MeetingResearch Awards. Leaders in8Society of Interventional Radiology + Society of Interventional Radiology Foundation

SIR Foundation grants allow recipients to pursue IR researchthat will further improve patient care.Innovation Award winner: Michael D.Dake, MD, FSIR. Dr. Gary J. BeckerYoung Investigator Award winner:Edward Lee, MD, PhD, MSc. Theseawards strengthen the specialtythrough increased research andeducation opportunities and highlightand promote excellence in innovation.• SIR Foundation established theSummer Medical Student ResearchInternship Program with a corporatehost/mentor and an IR host mentor.• SIR Foundation raised more than$400,000 to advance research andeducation for IR through the 2ndAnnual SIR Foundation Gala.• Manuscript submissions to the Journalof Vascular and Interventional Radiology(JVIR) are at their highest volume in thepast four years.Thanks to SIR Foundation’s summer medical student research internship, I spent eightweeks at Johns Hopkins University Medical School. I worked under Jeff H. Geschwind,MD, FSIR, studying how different metabolic rates in cancer cell lines can help us identifywhich chemotherapy drugs might be most effective. I had the opportunity to see firsthandthe stepwise progression of research from lab to hospital. It was great to work alongsidesomeone like Dr. Geschwind, who is very involved in high-quality research. The internshipwas a great preparation for my radiology residency.—Hans Michell, Florida International University, Herbert Wertheim College ofMedicine, SIR Foundation 2012 Summer Medical Student Research Intern• JVIR expanded its reach through anew iPad application, free to membersand subscribers, while garneringmore than 1,000 new submissions.The journal also maintains a two-yearrunning average of fewer than 30 daysto first decision for new submissions.• Building a strong evidence base in IR canonly thrive if data can be shared, analyzed,reported and integrated. In 2012, topromote standardized IR data collection,the Standards Division began developinga range of structured report templates:IVC filter insertion/removal, renal ablation,venous access/ports, uterine fibroidembolization and spinal interventions.These templates will eventually be madeavailable to SIR members.2012 Annual Report 9

EXTENDING GLOBAL REACHThere has been worldwide explosion of interest in interventional radiology in recent years. In response, SIR created theInternational Scholarship, a competitive program that introduces the Society to international IR leaders of the future.Inviting the World to SIRIn 2012, the inaugural SIR InternationalScholarship brought 12 representativesof nine countries, from Argentina toMongolia, to the Society’s Annual ScientificMeeting—individuals who otherwise mightnot have been able to attend. The meetinggave these scholars a greater sense ofthe scope and potential for interventionalradiology than they realized existed.As they participated in daily meetingsand attended receptions in a group, thescholars coalesced into a community oftheir own—enhancing the possibilities of atruly global IR community in the future.“I was privileged to attend the SIR 2012Annual Scientific Meeting as an SIRInternational Scholar—the first time I’dattended the SIR Annual Scientific Meeting.Thanks to the scholarship, I participatedin an excellent educational program andmet the most renowned interventionalradiologists of the United States and fromaround the world. The program coveredmore topics than I could have imaginedpossible; I was very impressed with thescientific studies that support interventionalradiology treatments—many of them firstrevealed during the SIR meeting.“My discussions with experts and fellowscholarship recipients were also beneficialand inspirational as I learned aboutthe constant growth and evolution ofinterventional radiology. I recommendapplying for an SIR International ScholarshipI think the most valuable aspect of the program was the two-way learning, as we surelylearned from them as well. At the end of the meeting, we brought the scholars togetherwith corporate sponsors, colleagues and peers. Each did a presentation on the state ofinterventional radiology in his or her home country and identified the profession’s mostpressing needs there. All attendees involved—not just the International Scholarshiprecipients—left the meeting better informed on the state of interventional radiology aroundthe world and how it might grow in the future.—Brian F. Stainken, MD, FSIR, Chair, Diagnostic Imaging Department,Roger Williams Hospital; Adjunct Professor, Boston University Schoolof Medicine; Chair, SIR International Task Forceto anyone interested in interventionalradiology.” —Sonny Chiu, MD, Hong KongGrowing IR Around the World• The inaugural SIR InternationalScholarship exceeded expectations. Ofthe 12 SIR International Scholars fromnine countries, three scheduled U.S.observerships after the SIR meetingand one scholar volunteered to serve asa JVIR reviewer.• Society representatives attendednumerous relevant meetings outside theUnited States:Canadian Interventional RadiologyAssociation (CIRA)Cardiovascular and InterventionalRadiological Society of Europe(CIRSE)Chinese Society of InterventionalRadiology (CSIR)Emboaires 2012, ArgentinaJapanese Society of InterventionalRadiology (JSIR)Sociedade Brasileira de RadiologiaIntervencionista e CirurgiaEndovascular (SoBRICE)• 2012 marked IR innovation aroundthe world (see a list of examples on thefacing page).• SIR’s new electronic newsletter,International Leadership Update,increased engagement and interactionwith IR societies in other countries andpromoted further collaboration via socialmedia platforms.• The JVIR editorial board now representsfive countries in six time zones.1.3+ MILLIONINDIVIDUALS HAD THE POTENTIAL TO SEE SIR’S NEWS ON FACEBOOKSIR’s Facebook fans hail from India, Egypt, Canada, Italy, the U.K. and Iraq10 Society of Interventional Radiology + Society of Interventional Radiology Foundation

2012 SIR InternationalScholarship RecipientsArgentinaPablo Rodriguez, MD, ArgentineSociety of RadiologyChileCristian Arriagada, MD, MBA, ChileanSociety of RadiologyChinaTianzhi An, MD, Hongjian Shi, MD,PHD, Hongshan Zhong, MD,Chinese Society of InterventionalRadiologyHong KongSonny Chiu, MD, MBChB, HongKong Society of IRIndiaPankaj Sharma, MD, MBBS, DMRD,DNB, PDCC, Indian Radiologicaland Imaging AssociationKoreaGyoung Min Kim, MD, HanmyunKim, MD, Korean InterventionalRadiology SocietyMongoliaUndrakh-Erdene Erdenebold, MD,Mongolian Society of IRSingaporeSivasubramanian Srinivasan, MBBS,MD, CVIR Subsection, SingaporeRadiological SocietyUnited KingdomCarla Gonzalez-Junyent, MD,Cardiovascular and InterventionalRadiological Society of EuropeRelevant Research From Aroundthe WorldThe Journal of Vascular and InterventionalRadiology attracts research from aroundthe world. Here are just some examplesof interesting work published in 2012,as selected by JVIR Editor-in-chief Ziv JHaskal, MD, FSIR.Argentina: KaposiformHemangioendothelioma with Kasabach-Merritt Phenomenon: SuccessfulTreatment with Embolization andVincristine in Two Newborns. Garcia-Monaco et al.Australia: Radioembolization vs.Standard Care of Hepatic Metastases:Comparative Retrospective CohortStudy of Survival Outcomes andAdverse Events in Salvage Patients.Bester et al.Canada: Vulnerable CarotidAtherosclerotic Plaque Creationin a Swine Model: Evaluation ofStenosis Creation Using Absorbableand Permanent Suture in a DiabeticDyslipidemic Model. Soulez et al.China: A Novel In Vivo Rabbit Model ofAbdominal Aortic Aneurysm Inducedvia Periarterial Incubation of Papain. Biet al.Germany: Multimodal Visibility of aModified Polyzene-F Coated SphericalEmbolicAgent for Liver Embolization:A Feasibility Study in a Porcine Model.Stampfl et al.Japan: Phase I/II Multi-Center Study ofTransarterial Chemoembolization witha Cisplatin Fine-Powder and PorousGelatin Sponge For UnresectableHepatocellular Carcinoma: JapanInterventional Radiology in OncologyStudy Group (JIVROSG) Study -0401.Osuga et al.Portugal: Prostatic arterial supply:anatomical and imaging findingsrelevant for selective arterialembolization. Bilhim et al.South Korea: Predictive Factors for theResponse of Peripheral ArteriovenousMalformations to Embolization Therapy:An Analysis of Clinical Data and ImageFindings. Park et al.Spain: Utero-ovarian anastomoses and theirinfluence on uterine fibroid embolization.Lanciego et al.Switzerland: Embolization formulticompartmental bleeding inhemodynamically unstable patients:Prognostic Factors and outcome, Bizeet al.The Chinese Society of InterventionalRadiology (CSIR) bestowed “HonorableMember” status on John A. Kaufman, MD,MS, FSIR, and Kieran J. Murphy, MD, FSIR(not pictured).2012 Annual Report 11

ENVISIONING THE FUTURE: MY VISION OF IR 10 YEARS FROM NOWIn 10 years, IR will finally be widely recognized as the specialty that has changed medicine on a grand scale—composed of unique, technical, sophisticated, comprehensive, disease-focused clinicians with specific skill andexpertise. Our research will have proven IR outcomes to be best, safest and most economical.Our cost effectiveness will stand out amidst the broad focus on health care expenditures, and health systems willreadily acknowledge the value and necessity of the IR clinicians. Interventional research will be widely populatedwith prospective and comparative studies. Using interventional oncology as an example, IR-led studies will havemoved us out of “salvage” and into first- and second-line therapy, while pipeline technologies will expand our horizons beyond what andhow we treat today.Our relentless and natural pursuit of innovation will have taught us how to succeed within a regulatory environment that creates silosand erects barriers to innovation. The continued efforts of SIR Foundation will drive research and support daily the ingenuity that definesus and brings widespread recognition to the specialty.The public will know what an interventional radiologist does and when to find one—that is, patients will view us as their doctors. Thespecialty will embrace more longitudinal care and equally house clinicians with surgical and medical backgrounds. More of us will moveinto outpatient settings. Many of us may subspecialize even further. And yet, future trainees around the world will enter the field viewingthemselves as primary doctors.—Ziv J Haskal, MD, FSIR, Editor-in-chief, Journal of Vascular and Interventional Radiology12 Society of Interventional Radiology + Society of Interventional Radiology Foundation

Scan this code to let SIR know your vision of the future of IR.Get the reader at www.gettag.mobi.Ten years from now, the Dual Primary Certificate in Interventional Radiology and Diagnostic Radiology will be theacknowledged norm; no more subspecialty VIR certificates will be awarded. As our increased range of offeringshelp to raise awareness of IR, we’ll enjoy better recognition by the public and payers, and payer directories will listinterventional radiologists separately. Doctors will refer patients directly to interventional radiologists. We’ll continueto see the field evolve in such areas as interventional oncology and women’s intervention, areas in which IRs willincreasingly subspecialize.There will be major developments in the IR suite around the world, emulating multimodality suites that incorporate multiple forms offeedback that is available on the fly.Interventional radiologists will be involved at both ends of disease care: more first-line treatment in early-stage disease as well as agreater role in palliation. We’ll be better able to treat early disease and perhaps surgery might not be necessary at all—not minimallyinvasive, but totally noninvasive.Interventional radiology will lead the way among radiology specialties in registries and acceleration of the path to best practices.I think the field will continue to innovate. Hopefully, noninvasive application of energies coupled with imaging will end up in the hands ofinterventional radiologists; this seems a natural path to becoming less invasive.—Gary J. Becker, MD, FSIR, Executive Director, American Board of Radiology;inaugural editor-in-chief, Journal of Vascular and Interventional RadiologyThe SIR Strategic PlanThe SIR Executive Council approved adoption of the 2013–2017 strategic plan, which will prioritize the next five years of Societyefforts around clinical care, outcomes data, revenue growth, building awareness of IR and innovation. SIR and SIR Foundation have aclear vision—that interventional radiology becomes the first choice for image-guided therapy—for health care professionals, consumers,legislators, reporters, regulators, private and federal funding sources and insurers.The plan charts the course for strategically building on our history and strengths, setting clear priorities and making a bold investment inour members. Our goals are to ensure that:1 Every interventional radiologist provides longitudinal care;2 We develop a standardized outcomes data infrastructure;3 The Society achieves a net revenue to provide the resources necessary to fund defined goals;4 Key decision makers understand what IR is, does and achieves; and5 Interventional radiologists lead the medical profession in innovation.2012 Annual Report 13

MESSAGE FROM THE TREASURERFinancial update on the SocietyBuilding off of increased investment inprogramming and initiatives in FY 2011,SIR continued to provide increasedmember value and services to itsmembers. With sustained growth ofinitiatives and educational activities, theorganization operated on a balancedbudget compared to a net operatingloss of $174,572 in 2011. The Society’snet operating loss in 2012 was $587.Revenues for the year were up 2.1% compared to 2011. Theincrease in revenue can be attributed to an increase in membershipdues received, increased revenue from product sales, and thecontinued growth of revenue streams from registration andcorporate support for educational programming. New nonduesrevenue streams in 2012 included SIR Press offerings suchas Updates in Interventional Radiology 2012, a successful fallWebinar series that touched on topics like renal artery stenosisand locoregional liver therapy, and digital sales of Annual ScientificMeeting and other educational meeting content. A couple moreproduct sales or registrations from these events would have put theSociety in the black in 2012.Expenses for the Society remained flat compared to 2011 andwere down $3,935 from the prior-year audited financials. TheSociety also continued its dedication to research by donating$200,000 in unrestricted funds to SIR Foundation to help fundthe grants program, research consensus panels (RCPs) andother Foundation projects that will benefit both organizations andadvance the field of IR through basic science and clinical research.Financial update on SIR FoundationAs with the Society, SIR Foundation activities in 2012 continuedto build off the programming growth of 2011. Increased cash flowfrom the pledge commitments of the corporate and membershipphase of the Discovery Campaign began to flow into theorganization and fund grant, research and clinical programs. Totalcash received and new commitments to the Discovery Campaigntotaled $884,610 in 2012. This was aided by revenue raisedduring the 2nd annual Foundation Gala, and increased AnnualFund contributions from members, which brought in an additional$185,860 during the year.In FY 2012, the Foundation awarded and paid $302,000 in variousgrant categories and awards. The Foundation also continued to fundthe IO Registry project and an RCP on the management of criticallimb ischemia. The Foundation also launched a new medical studentinternship program in 2012 that introduced medical students early intheir studies to IR research and medical device development.In order to continue to fund these programs at this level, theFoundation must continue to receive all money pledged duringthe membership phase of the Discovery Campaign, and receiveincreased Annual Fund contributions from SIR members.During summer 2012, the SIR Executive Council and SIRFoundation board of directors approved a strategic plan for thenext five years that will align the missions and resources of bothorganizations to meet member needs. SIR and SIR Foundationwill continue to invest in strategic plan goals that will createmultiple avenues for advancing patient care and that will supportIR. These goals will include leading the medical profession ininnovation, increasing awareness of IR through outreach to keydecision-makers (policy/public) and our colleagues around theworld, develop a standardized outcomes data infrastructure tosupport the increasing demands of evidence-based medicinerequirements, expand physician participation in longitudinal care,and increase the revenue streams of both organizations so wecan successfully meet these goals.The Society and Foundation will be tackling these significantinitiatives over the next five years. In 2013, the organizationwill invest in the infrastructure that will allow the Society toaddress these goals successfully and transform how we supportand advance the specialty. I am confident that SIR and SIRFoundation are in a position to continue to invest in IR and addressmembership needs. This could not be achieved without the supportof our corporate partners, our loyal members, our committedmember volunteers, and our dedicated staff who invest so much oftheir time and energy to the success of our specialty every day.Sincerely,Charles E. Ray Jr., MD, PhD, FSIR14 Society of Interventional Radiology + Society of Interventional Radiology Foundation

THANK YOU TO OUR DONORSJodi GilardiBrian Giles, MDBlair G. Gill, MDAmanjit S. Gill, MDDaniel Gillespie, MDRimas P. Gilvydis, MDMichael S. Girard, MDChris Glenn, MDDmitry Goldin, MDMonte E. Golditch, MDNeil K. Goldstein, MDNazar Golewale, MDRod Golovoy, MDJafar Golzarian, MDMaria R. Gomes, MDShaun J. Gonda, MDArturo D. Gonzalez, MDJustin M. Gooding, MDJay D. Goodman, MDWhitney J. Goodwin, MDScott C. Goodwin, MD, FSIRCharles S. Gordon, MDGaurav K. Goswami, MDB.J. Gralino, Jr., MDWilliam Grande, MDClement J. Grassi,MD, FSIRRichard J. Gray, MD, FSIRW. Lawrence Greif, MDFrancis G. Greiner, MDRobert E. Gress, MDChristopher Gribbin, MDBryan R. Grieme, MDGerald R. Grossman, MDClifford N. Grossman, MDRobert C. Guay, Jr., MDGuerbet, LLCSebouh A. Gueyikian, MDCharles A. Guidot, MDMarcelo S. Guimaraes, MDRavindra Gullipalli, MBBS,MRCS, FRCRSanjay Gupta, MDRichard A. Haas, MDLabib F. Haddad, MDDwight P. Hager, MDEugene Hagiwara, MDJong S. Hahn, MDNeil J. Halin, DO, FSIRMichael J. Hallisey, MD, FSIRRamon Halum, III, MDMichael H. Hamblin, MDHerbert E. Hamilton, MDJohn A. Hancock, MDBryan C. Hankins, MDSue E. Hanks, MD, FSIRAnthony F. Harewood, MDColleen P. Harker, MDRichard J. Harp, MDAndrew Hartigan, MDPatrick A. Harty, MDZiv J Haskal, MD, FSIRNoel C. Haskins, MDGeoffrey S. Hastings, MDMarkus Hauser, MDMr. Kem HawkinsStuart C. Head, MDAnthony N. Hein, MDDavid A. Henry, MDKevin P. Henseler, MDBrent D. Herbel, MDMichael MervinHerskowitz, MDDavid R. Hertzog, MDRyan M. Hickey, MDMarshall E. Hicks, MD,FSIRRobert A. Hieb, MD, FSIRPaul Hiette, MDJeffrey Scott Hilger, MDShozo Hirota, MDKevin S. Hirsch, MDPaul Ho, MDEamonn P. Hobbs, FSIRJason C. Hoffmann, MDStephen L. Hofkin, MDMark J. Hogan, MDJeremy R. Hogg, MDElias S. Hohlastos, MDGeorge Holland, MDStephen Holtzman, MDSue HolzerMinoru Honda, MDRichard Hong, MDKent R. Hootman, MDJon D. Horn, MDTimothy C. Hou, MDJeffrey Howard, MDConnie Hsu, MDCharles M. Hubeny, MDEdwin Robert Hudson, MDEric A. Huettl, MDJeffrey E. Hull, MDMichael M. Hummel, MDStephen J. Hunt, MD, PhDDrew Clifford Hunter, MDJeffrey K. Hussey, MD, FRCRJames W. Husted,MD, FSIRTung V. Huynh, MDGloria L. Hwang, MDEric A. Hyson, MDFernando F. Illescas, MDMohammad Ilyas, MDPatrick R. Inscore, MDCharbel IshakDr. William A. Jackson, MDWilliam Thomas Jacoby, MDAbdel Aziz A. Jaffan, MDMarcy B. Jagust, MDThomas Jahnke, MD, FSIRBrandt A. Jamroz, MDB. Janne D’Othee, MD, MPH,FSIRRavi J. Jhaveri, MDJennifer Johnson, MDMatthew S. Johnson, MD, FSIRBradley A. Johnson, MDBrian G. Johnson, MDNeal Joseph, MDShellie C. Josephs, MDChristopher R. Joy, MDSidney L. Kahn, MDSanjeeva P. Kalva, MD, FSIRAvinash Kambadakone Ramesh,MDRobert E. Kamieniecki, MDJay W. Kang, MDMichael D. Kaplan, MDGregory C. Karnaze, MDBenjamin E. Kassanoff, MDSaravanan Kasthuri, MDManoj K. Kathuria, MDChandra S. Katragadda, MDMichael Katz, MDPhilip B. Katz, MDShannon L. Kauffman, MDJohn A. Kaufman,MD, FSIRDennis Kay, MD, FSIRSahira Kazanjian, MDLawrence J. Keating, MDGregory M. Keck, MDStephen T. Kee, MD, FSIRMark W. Keenan, MDFrederick S. Keller,MD, FSIRMichael J. Kelley, MD, FSIRLawrence R. Kelly, MDRobert J. Kennedy, MDRobert K. Kerlan, Jr., MD, FSIRArshad Ahmed Khan, MDNeil M. Khilnani, MDGeorge Khoriaty, MDSteven G. Kikolski, MDRobert Y. Kim, MDCharles Y. Kim, MDHyung S. Kim, MDDong Hyuck Kim, MDMoonjohn Kim, MDCarl Kim, MDThomas B. Kinney, MD, MSME,FSIRJohn W. Kish, MDArnold J. Klein, MDRobert J. KnebelJesse R. Knight, MDDavid Knight, MDTimothy M. Koci, MDElsie Koh, MDKenneth J. Kolbeck, MD, PhDKimi L. Kondo, DOTodd L. Kooy, MDRajah V. Koppala, MDBrian E. Kouri, MDPaul C. Koutras, MDChristopher M. Kowalski, MDStewart W. Kribs, MD18 Society of Interventional Radiology + Society of Interventional Radiology Foundation

Suzanne M. Slonim, MD, FSIRDavid J. Smith, MDTony P. Smith, MD, FSIRSteven J. Smith, MDJason C. Smith, MDBenjamin B. Smith, MDRussel D. Smith, MDDavid L. Smoger, MDEva M. Smorzaniuk, MDRonan H. Smyth, MDGregory M. Soares, MD, FSIRConstantinos T. Sofocleous, MD,PhD, FSIRJ. Louis Solis, MDStephen B. Solomon,MD, FSIRHo-Young Song, MDFelix L. Song, MDAjay Sood, MDDavid R. Sopko, MDNorman S. Sorkin, MDThomas A. Sos, MD, FSIROscar Sosa, MDMichael C. Soulen, MD, FSIRGilles P. Soulez, MDJames W. Spain, MD, PhDElizabeth B. Spencer, MDJames B. Spies, MD, MPH, FSIRAnthony W. Spinelli, MDEfstathios Spinos, MDSt. Jude Medical FoundationKevin S. Stadtlander, MDBrian F. Stainken, MD, FSIRMichael S. Stecker,MD, FSIRJoseph R. Steele, MDJoseph R. Stock, MDLeAnn Stokes, MDCarolyn Strain, MA, MSRichard Strax, MD, FACRBradley T. Strnad, MDJohn J. Strobel, MDCraig R. Suchin, MDKevin L. Sullivan, MD, FSIRHao Sun, MDJohn E. Sunderland, MDDaniel M. Sutton, MDCharles S. Sutton, MDPaul J. Svigals, MDTimothy L. Swan, MDMubin I. Syed, MD, FSIR, FACRKenneth E. Symington, MDDaniel Sze, MD, PhD, FSIRJeffrey H. Takahashi, MDAdam D. Talenfeld, MDAlda L. Tam, MDGuillermo J. Tanaka, MDNoboru Tanigawa, MDRoger P. Tart, MDRobert Tartaglione, MDCharles F. Tate, III, MD, FACRMs. Kathy W. Taylor, NPJordan Taylor, MDMichael A. Taylor, MDFrank C. Taylor, MD, FSIRT. Lamar Teaford, MDJames S. Teal, MDCorey L. Teigen, MDDavid L. Tempkin, MDColin TennebarWilliam Tew, MDRajiv P. Thakur, MDJames W. Thomas, MD, MBAJohn JT Thomas, MDJamie L. Thomas, DOJames D. Thomasson, Jr., MDRaymond H. Thornton, MD, FSIRCorito S. Tolentino, MDJohn Tomashek, MDBrandon S. Tominna, MDKenneth R. Tomkovich, MDRichard E. Toran, Jr., MDVenkat P. Tummala, MDVincent J. Turiano, MDThomas U. Tuten, MDSean M. Tutton, MD, FSIRAndre Becker Uflacker, MDAlozie I. Uneze, MDJonathan J. Uy, MDVenu Vadlamudi, MDDuane John Vajgrt, MDCarl N. Valentin, MDRichard J. Van Allan, MDArina Van Breda, MD, FSIREric A. Vander Woude, MDManish K. Varma, MDJay D. Varma, MDSuresh Vedantham, MD, FSIRCarl D. Vegas, MDThomas E. Velling, MDChandrasekar Venugopal, MDChido Dorothy Vera, MDRajiv Verma, MDAnthony G. Verstandig, MDAthanasios Vlahos, MDNghia Jack Vo, MDRoxanne WadeDaniel WaiglThomas Gregory Walker, MD,FSIREric M. Walser, MDArthur C. Waltman, MD, FSIRMichael P. Wang, MDEric A. Wang, MDJ’Andre O. Ward, MDRoy WatsonWalter Weakland Jr.James R. Weeks, Jr.,MDSteven J. Wegert, MDDaniel J. Wegner, MDJeffrey A. Weil, MDMichael J. Weiner, MDLori M. Weir, MDRichard Welcome, MDJames Wells, III, MDMark Allen Wendel, MDGabriel Werder, MDDaniel E. Wertman, Jr., MDKurt H. Wetzler, MDKevin E. White, MDThomas W. White, MDRobert I. White, Jr.,MD, FSIRDavid M. Widlus, MDBret N. Wiechmann,MD, FSIRPhilip M. Wildenhain, MDTerrence D. Wilkin, MDJamison L. Wilson, MDMark W. Wilson, MDGerhard R. Wittich, MDWayne A. Wivell, MDJoan C. Wojak, MD, FSIRJulie WolfeAdrian A. Wong, MDDavid H. Woo, MDRobert Wood, Jr., MDRobert L. Worthington-Kirsch,MD, FSIRRichard John Wunder, MDDaniel J. Wunder, MD, CAQ IRAlex M. Wurm, MDThaddeus M. Yablonsky, MDMarshall E. Yacoe, MDWayne F. Yakes, MD, FSIRRyusaku Yamada, MD, FSIRGrant J. Yanagi, MDTerry D. Yeager, MDRamana V. Yedavalli, MDDominic Carl Yee, MDDouglas B. Yim, MDCharles D. Yim, MDJames A. York, MDCarol M. Younathan, MDHyeon Yu, MDJulie M. Zaetta, MDJ. Werner Ziegler, MDStan Zipser, MD, JDDarryl A. Zuckerman, MD, FSIRChristopher M. Zylak, MD2012 Annual Report 21

SIR EXECUTIVE COUNCILMarshall E. Hicks, MD, FSIRPresidentScott C. Goodwin, MD, FSIRPresident-electJames B. Spies, MD, MPH, FSIRSecretaryCharles E. Ray Jr., MD, PhD, FSIRTreasurerTimothy P. Murphy, MD, FSIRImmediate Past PresidentGeorge A. Fueredi, MD, FSIRHealth Policy and Economics DivisionJohn A. Kaufman, MD, MS, FSIRSIR Foundation ChairGary P. Siskin, MD, FSIRAnnual Scientific Meeting DivisionDaniel A. Siragusa, MD, FSIRGraduate Medical Education DivisionBrian Funaki, MD, FSIRPostgraduate Medical Education DivisionMatthew S. Johnson, MD, FSIRMember Services DivisionBoris Nikolic, MD, MBA, FSIRStandards DivisionSuresh Vedantham, MD, FSIRCouncilor-at-largeSanjay Misra, MD, FSIRCouncilor-at-largeJeff H. Geschwind, MD, FSIRCouncilor-at-largeZiv J Haskal, MD, FSIRJVIR Editor (ex-officio)John D. Fulco, MD, FSIRAMA Delegate (ex-officio)Susan E. Sedory Holzer, MA, CAEExecutive Director (ex-officio)Tricia McClennyAssociate Executive Director (ex-officio)22 Society of Interventional Radiology + Society of Interventional Radiology Foundation

SIR FOUNDATION BOARD OF DIRECTORSJohn A. Kaufman, MD, MS, FSIRChairStephen T. Kee, MD, FSIRVice ChairGordon McLennan, MD, FSIRImmediate Past ChairCharles E. Ray Jr., MD, PhD, FSIRTreasurerKamran Ahrar, MDClinical Research Trials ChairFilip Banovac, MDResearch Policy ChairFrancis Facchini, MD, FSIRDevelopment ChairLaura Findeiss, MD, FSIRResearch Education ChairGeorge A. Fueredi, MD, FSIRSIR Economics CouncilorScott C. Goodwin, MD, FSIRSIR President-electZiv J Haskal, MD, FSIRJVIR Editor (ex-officio)Marshall E. Hicks, MD, FSIRSIR PresidentDaniel A. Siragusa, MD, FSIRSIR Education CouncilorSusan E. Sedory Holzer, MA, CAESIR Executive Director (ex-officio)Carolyn Strain, MA, MSSIR Foundation Executive Director(ex-officio)2012 Annual Report 23

3975 Fair Ridge Drive, Suite 400 North + Fairfax, VA 22033(703) 691-1805 + Fax (703) 691-1855www.SIRweb.org • www.SIRFoundation.orgMAKING A WORLD OF DIFFERENCE + MAKING A DIFFERENCE IN THE WORLD

More magazines by this user
Similar magazines